The clinical utility of the Mattis Dementia Rating Scale in assessing cognitive decline in Alzheimer's disease

被引：6

作者：

Miller, Julie M. ^{[1
]}

Pliskin, Neil H. ^{[1
]}

机构：

[1] UIC, Dept Psychiat, Chicago, IL 60610 USA

来源：

INTERNATIONAL JOURNAL OF NEUROSCIENCE | 2006年 / 116卷 / 05期

关键词：

Alzheimer's disease; dementia; Mattis Dementia Rating Scale;

D O I：

10.1080/00207450600592164

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

The progression of cognitive decline in Alzheimer's disease ( AD) was studied by examining patterns of test performance on successive administrations of the Mattis Dementia Rating Scale ( DRS) in a sample of 63 participants who were diagnosed with probable AD. Assessments were performed at intervals ranging approximately from 3 to 38 months apart. Results indicated that the pattern of progression and sequence of neuropsychological decline in AD is influenced by sex and age of disease onset. Results offered support for the clinical staging of AD and further substantiated the clinical utility of the Mattis Dementia Rating Scale in staging degree of dementia.

引用

页码：613 / 627

页数：15

共 43 条

[21] Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease: A CERAD analysis .12. [J].